ArticleHemaSphere2021

Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance.

Stephen Boyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.